Not all protein powders are created equal. Find the right one for you at Vega
Not all protein powders are created equal. Find the right one for you at Vega Save up to 20% on best-selling protein powder, creatine, pre-workout and more Vega supplements.
With Memorial Day weekend right around the corner, this is often the time of year when people start embracing 'cutting season.' Cutting is a period of time dedicated to reaching your fitness and nutrition goals by reducing body fat and maintaining muscle. Whether you're trying to feel more confident on your upcoming summer beach vacation or fit into a great wedding outfit, your fitness goals change as the seasons do.
Vega is here to help you achieve all your goals with a little boost from popular protein, creatine, pre-workout and other supplements. The health and wellness brand offers protein powders and more with clean ingredients that are vegan, gluten-free and lactose/dairy-free so you know they're easy on your stomach no matter your dietary restrictions.
Here are some of the top protein options from Vega:
Shop best-selling Vega protein and wellness products
Combine protein and creatine for muscle growth
HOME GYM SALE: Build your at-home gym with up to 27% off Merach vibration plates, bikes and ab machines 💪
Power through your workout with an energy supplement
More: Here are the 10 supplements I take while on my Zepbound weight loss journey
Support your overall nutrition goals
Shop all Vega products
Which protein powder is right for me?
There are a few things to consider about your health and fitness journey before deciding on a protein powder.
WELLNESS GOALS: Is wellness your goal? Use our exclusive iHerb code to save on vitamins, supplements and more
How to choose supplements based on your health and fitness goals
Want to build muscle or enhance strength? Look for a whey protein isolate which allows for fast absorption.
Look for a whey protein isolate which allows for fast absorption. Focused on weight loss or meal replacement? A whey protein isolate is also a great option here, and there are plenty of low-calorie and low-carb options.
A whey protein isolate is also a great option here, and there are plenty of low-calorie and low-carb options. Need a general health and diet supplement? Look for a whey concentrate or plant-based blend which offers both balanced and affordable options.
Want healthier hair? Try Nutrafol and get $10 off your first month
Consider your dietary restrictions
Lactose intolerant : Choose a whey isolate, or plant-based option.
: Choose a whey isolate, or plant-based option. Allergies : Read labels carefully to avoid key ingredients like soy, dairy and nuts.
: Read labels carefully to avoid key ingredients like soy, dairy and nuts. Gluten-free or Keto? Many protein powders are labeled accordingly, but look for certifications.
More: Men can easily manage weight loss, hair growth and sexual wellness with Hims
Check the ingredients label for your preferences
Clean labels and no artificial sweeteners - Look for organic or minimally processed brands.
Look for organic or minimally processed brands. Flavored vs. unflavored - Flavored proteins tend to be easier going down, but unflavored protein is easier to mix into recipes.
Still need help? Vega offers a great quiz about your fitness and nutrition goals that can help you decide which product is best for you.
Take the Vega quiz
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hill
2 hours ago
- The Hill
Beyond MAHA: Defeating obesity requires a new strategy
Obesity is a major health problem facing our country. According to the CDC, more than 40 percent of the U.S. population is obese, defined as having a body-mass index above 30. As astounding at that number is, it is perhaps even more surprising that nearly 20 percent of children in the U.S. are obese. Obesity leads to significant health challenges, including diabetes, stroke, cardiovascular disease and liver disease. It is clear that as a nation we must face this crisis on multiple fronts. Diet and exercise certainly help, and it's critical to ensure that people of all socioeconomic backgrounds have access to healthy foods (free of preservatives, unnecessary dyes, high fructose corn syrups etc.) and are educated in making healthy lifestyle choices. The MAHA or 'Make America Healthy Again' movement has highlighted this as one of its key objectives, and if it is successful, we should see an impact on obesity — especially in children, where diet and exercise have a huge impact on weight-related health outcomes. Obesity in adults, however, is often more challenging. Many adults with obesity struggle to lose weight, despite considerable efforts to modify their lifestyle through diet and exercise. This is because our metabolism changes as we age, and many adults who are overweight develop metabolic dysfunction or 'metabolic syndrome,' which then further perpetuates weight gain and exacerbates the situation. It has become clear in recent years that many people struggling with obesity require medical intervention – not just lifestyle intervention – and that prescriptions can substantially improve weight loss. The explosion in use of GLP-1 agonists, such as Wegovy and Zepbound, over the last two years has underscored the need for medical intervention in obese and overweight patients. Currently, about 6 percent of the U.S. population, or 15 million people, are on GLP-1 weight loss treatments, and the numbers are only expected to increase. However, while most patients lose 10 percent to 25 percent of their body weight while on a GLP-1, they do not maintain GLP-1 treatment in the long-term, with approximately 80 percent of patients discontinuing treatment within 1 year. Gastrointestinal side effects, injectable administration, and high cost have prevented long-term use of GLP-1's for weight maintenance. And unfortunately, most patients gain back all the weight after stopping the medication. Healthcare professionals and the pharmaceutical industry now recognize that obesity — like most other medical conditions — requires an 'arsenal' of treatments, rather than a one-size-fits-all approach. Post-GLP-1 weight maintenance is now widely recognized as an emerging unmet need. And patients who are not candidates for or cannot tolerate GLP-1s require alternatives. Diet and lifestyle modifications are important alongside prescription medications in fighting obesity. If we are going to be successful in overcoming this major health crisis, we need to ensure that both the pharmaceutical industry and groups like MAHA work hand in hand. Both treatment and prevention are critical in order to regain control of our nation's health. Dr. Shoshana Shendelman, Ph.D. is a scientist and entrepreneur who has founded numerous biotech companies. She is a pioneer in the development of drugs and therapeutics for rare and underserved diseases. Currently she is Vice Chair of the Advisory Board of Columbia University Medical Center and Columbia University Vagelos College of Physicians and Surgeons.
Boston Globe
21 hours ago
- Boston Globe
Biden's doctor failed to properly assess fitness for office, Obama's doctor says
The rare criticism of one White House doctor by another comes as Republicans have increased scrutiny of O'Connor and other former White House aides. House Republicans subpoenaed O'Connor on Thursday, a day after President Donald Trump ordered White House attorneys to determine whether Biden's inner circle tried to conceal his alleged cognitive decline. Get Starting Point A guide through the most important stories of the morning, delivered Monday through Friday. Enter Email Sign Up Kuhlman also said the 2024 report merely assessed Biden's health when it should have considered his fitness to serve in one of the most taxing jobs on the planet. Advertisement 'It shouldn't be just health, it should be fitness,' Kuhlman said. 'Fitness is: Do you have that robust mind, body, spirit that you can do this physically, mentally, emotionally demanding job?' O'Connor did not respond to repeated requests for comment. Biden's recent disclosure of metastatic prostate cancer and reporting about his alleged physical and cognitive decline have fueled suspicion - among Democrats as well as Republicans - that the true state of Biden's health toward the end of his term was known only by O'Connor and a few others closest to Biden. Advertisement Journalists Jake Tapper and Alex Thompson sketched a picture of a well-meaning but weakened president in a book they released last month. The book, which draws on interviews with dozens of Democratic insiders after the 2024 election, paints a portrait of a man suffering at times from forgetfulness, incoherence and fatigue. It also says that O'Connor was reluctant to give Biden a cognitive test, though he was assessed by a neurologist for conditions such as Parkinson's disease. Biden gave a sarcastic response last week. 'You can see that I'm mentally incompetent, and I can't walk, and I can beat the hell out of both of them,' he told reporters at a Memorial Day event, apparently referring to Tapper and Thompson. Biden's granddaughter Naomi Biden has called the book 'political fairy smut.' The book isn't the first time Biden's cognitive state has been questioned. Special counsel Robert K. Hur said in February 2024 that Biden had 'limited precision and recall' - including not remembering when his vice-presidential term ended - after Hur conducted two days of interviews with Biden about his handling of classified documents. Kuhlman formerly worked alongside O'Connor in the White House medical unit, a nonpartisan post, and appointed him in 2009 to serve as then-Vice President Biden's personal doctor. Kuhlman was Obama's physician from 2009 to 2013. O'Connor examined Biden - and signed his name to the February 2024 medical report that said the president 'continues to be fit for duty' - four months before a disastrous campaign debate between Trump and Biden prompted Democrats to call for Biden to step down as the nominee. Advertisement Kuhlman, who left the medical unit in 2013, said he tries not to criticize those who have held similar positions. He called O'Connor 'a good doctor' who seemed to do his best to 'give trusted medical advice.' 'I didn't see that he's purposely hiding stuff, but I don't know that,' he said. 'Maybe the investigation will show it.' Kuhlman wrote a 2024 book about his experiences in the White House Medical Unit in which he argued for cognitive testing for older candidates and presidents. O'Connor's six-page report included Biden's lab results and an explanation of various conditions for which he was being treated. It also listed 10 medical specialists, including a neurologist, who also examined Biden. 'President Biden is a healthy, active, robust 81-year-old male, who remains fit to successfully execute the duties of the presidency,' O'Connor wrote. White House doctors have long been under intense public scrutiny, balancing the deeply personal doctor-patient relationship with a responsibility to tell the American public whether the president is fit to serve - and if not, why. Some have gone to great lengths to hide when the president is severely ill - as Grover Cleveland's doctors did when they turned a yacht into an operating room to secretly remove a tumor from the president's mouth in 1893. Presidential physicians also are expected to communicate to Americans personal information about the very person who could fire them. 'Whether it's family who are worried for them or people who work for them and don't want to lose their jobs, no one has a vested interest in hearing the truth about the president's health - except for the American people and the world,' said Barbara Perry, a presidential historian at the University of Virginia. Advertisement It has not always been clear what role the White House doctors see for themselves. Even as they are often close confidants of the president, they must consider the good of the country in their recommendations about what tests and treatments to pursue. O'Connor repeatedly refused last year to administer a cognitive exam to Biden even as aides privately expressed concerns about his mental fitness, according to Tapper and Thompson's book. Trump's former doctors, including Ronny Jackson and Sean Conley, have at times sounded more like cheerleaders for the president than sober judges of his health. His current doctor, Sean Barbabella, mentioned Trump's 'frequent victories in golf events' in the first medical report of his second term. Jackson suggested to the media in 2018 that Trump had 'incredibly good genes' and joked that he might live to 200 years old if his eating habits were more healthful. Jackson, now a Republican congressman from Texas, was demoted by the U.S. Navy after an inspector general report shed light on multiple misdeeds involving alcohol and harassment while he served in the White House medical unit. Conley, who succeeded Jackson, repeatedly downplayed the severity of Trump's symptoms when he was hospitalized with covid-19 in the fall of 2020. Past presidents who didn't want the public to know the truth about their poor health have orchestrated elaborate cover-ups. After Woodrow Wilson suffered a major stroke in 1919, leaving him with a paralyzed left side, his doctor conspired with Wilson's wife to keep his condition hidden from his own Cabinet. Advertisement Cleveland insisted the operation to remove his tumor be secretly performed on a friend's yacht, under the guise that he was on a fishing trip near his summer home on Long Island. The administration denied an initial report about the surgery, and the truth wasn't widely accepted until after Cleveland's death many years later, when one of his doctors publicly confessed. On the other hand, Dwight D. Eisenhower reportedly ordered his press secretary to 'tell them everything' after suffering a heart attack in 1955. His surgeons regularly briefed the public after his heart surgery. But medical transparency is only as strong as the president wants it to be. Like regular Americans, the president is protected by medical privacy laws, so disclosing any health information is ultimately up to him. An additional challenge, former White House doctors and presidential historians say, is that there is no official requirement for how often a president should undergo an exam, what the exam should include and which of the results should be made public. 'There's nothing codified about what to do,' said Kuhlman, who also served on the White House medical unit under George W. Bush. White House doctors traditionally conduct an annual physical exam on the president and release a memo of varying length that includes vital signs, a summary of the physical examination and the results of blood tests. These memos generally conclude with some kind of pronouncement from the doctor that the president is fit to execute the duties of the presidency. Trump's and Biden's doctors have largely followed that pattern, although the reports on Biden's health have been significantly longer and more detailed than the reports on Trump. Advertisement Kuhlman and Lawrence Mohr, who served as physician to Ronald Reagan and George H.W. Bush, said they were never asked by any president to withhold medical information in their reports. Mohr said he recalls that there was 'never any question' about being candid about the president's health. 'You never lie; never, never say anything that's not true,' Mohr said. 'You put out a clear press release about what's going on, what to expect and you get it out there. If you don't do that, you end up with all sorts of speculation.' Reagan was 77 when he left office and five years later announced he had Alzheimer's disease. He faced similar questions about his fitness to serve. Mohr recollected administering the Mini-Mental State Examination - a test used to assess cognitive function - to the 40th president. Trump's doctors have given him a different cognitive test, the Montreal Cognitive Assessment. But cognitive tests are not standard practice. Neither George W. Bush nor Obama took one, Kuhlman said. But they were much younger while in office than Biden. 'I was fortunate to have 50-year-old patients instead of 80-year-old ones,' Kuhlman said.
Yahoo
21 hours ago
- Yahoo
Lilly partners with Camurus in search of a long-lasting obesity drug
This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free daily BioPharma Dive newsletter. Looking to defend its giant cardiometabolic health franchise, Eli Lilly is licensing a technology from Swedish biotechnology firm Camurus that promises to produce longer-acting medications. Camurus' FluidCrystal technology is designed to methodically release a therapeutic drug substance into the body over a period of days or months. After an injection, the solution interacts with bodily fluids to transform into a liquid crystalline gel. The gel holds the active ingredient and then slowly degrades, releasing medicine. The deal includes an unspecified upfront payment as part of an initial package that may be worth as much as $290 million, Camurus said Tuesday. That figure also includes payments for reaching certain development and regulatory milestones. Another $580 million could be available for meeting sales goals, along with mid-single digit royalties for successful products. Lilly and rival Novo Nordisk revolutionized diabetes and obesity treatment over the last few years with GLP-1 medicines that opened up one of the biggest markets the pharmaceutical industry has ever seen. In the first quarter alone, Lilly raked in more than $6 billion from sales of tirzepatide, sold as Mounjaro for diabetes and Zepbound for obesity. Novo brought in even more from its Ozempic and Wegovy. Now Lilly and Novo are faced with defending the market as a raft of competitors vie to offer newer and better options. Both companies have bulked up their pipelines; Lilly recently claimed success in a Phase 3 trial of a GLP-1 medicine that can be taken in pill form instead of injection. It also has a triple-acting drug in development and a number of other experimental medicines that work differently. The Camurus deal allows Lilly to apply the long-acting technology to as many as four of its drug compounds. That may help the company stave off competitors such as Metsera, which in January announced promising research for its experimental long-acting GLP-1 shot. Meanwhile, Roche recently announced a $1.65 billion deal to expand its obesity pipeline and Amgen and Viking Therapeutics are both moving into late-stage studies of potential rival treatments. Companies are also working on ways to augment the Lilly and Novo medicines. Veru is testing a drug designed to help preserve muscle when taken with Novo's Wegovy. Regeneron and others are conducting similar research. Recommended Reading Novo inks Ascendis deal to develop long-acting GLP-1, other metabolic drugs
